Alongside this, a notable overall decrease in gene expression patterns correlated with genes showing closed chromatin states at the promoter region in the resistant cell line, underscoring the epigenome’s role as a regulator of resistance in HER2-positive breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.